State of New Jersey Common Pension Fund D’s Compass Therapeutics CMPX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CMPX Stock Details CMPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$202K	Buy	+38,113	New	+$220K	﹤0.01%	1529

Other funds holding CMPX

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State of New Jersey Common Pension Fund D's CMPX Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in Compass Therapeutics (CMPX) in Q1 2026: 38,113 shares worth $202K. The stake represents ﹤0.01% of the portfolio and ranks #1529 among its holdings.

201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

State of New Jersey Common Pension Fund D held 38,113 shares of Compass Therapeutics worth $202K as of Q1 2026.
Compass Therapeutics was a new State of New Jersey Common Pension Fund D position in Q1 2026.
Compass Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1529 holding.
201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.